Singapore markets closed

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
124.51-0.89 (-0.71%)
At close: 04:00PM EDT
124.36 -0.15 (-0.12%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 564.56B
Enterprise value 564.10B
Trailing P/E 46.44
Forward P/E 37.59
PEG ratio (5-yr expected) 2.40
Price/sales (ttm)16.73
Price/book (mrq)36.21
Enterprise value/revenue 2.43
Enterprise value/EBITDA 4.92

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 345.57%
S&P500 52-week change 323.42%
52-week high 3138.28
52-week low 375.56
50-day moving average 3125.48
200-day moving average 3102.68

Share statistics

Avg vol (3-month) 35.07M
Avg vol (10-day) 33.5M
Shares outstanding 54.46B
Implied shares outstanding 64.53B
Float 83.19B
% held by insiders 10.00%
% held by institutions 19.28%
Shares short (28 Mar 2024) 42.83M
Short ratio (28 Mar 2024) 40.5
Short % of float (28 Mar 2024) 4N/A
Short % of shares outstanding (28 Mar 2024) 40.06%
Shares short (prior month 29 Feb 2024) 44.88M

Dividends & splits

Forward annual dividend rate 41.37
Forward annual dividend yield 41.10%
Trailing annual dividend rate 39.40
Trailing annual dividend yield 37.50%
5-year average dividend yield 41.63
Payout ratio 437.84%
Dividend date 302 Apr 2024
Ex-dividend date 422 Mar 2024
Last split factor 22:1
Last split date 320 Sept 2023

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 36.03%
Operating margin (ttm)42.79%

Management effectiveness

Return on assets (ttm)23.39%
Return on equity (ttm)88.07%

Income statement

Revenue (ttm)232.26B
Revenue per share (ttm)51.81
Quarterly revenue growth (yoy)37.00%
Gross profit (ttm)N/A
EBITDA 109.81B
Net income avi to common (ttm)83.68B
Diluted EPS (ttm)2.68
Quarterly earnings growth (yoy)61.60%

Balance sheet

Total cash (mrq)30.23B
Total cash per share (mrq)6.78
Total debt (mrq)27.01B
Total debt/equity (mrq)25.34%
Current ratio (mrq)0.82
Book value per share (mrq)23.90

Cash flow statement

Operating cash flow (ttm)108.91B
Levered free cash flow (ttm)54.1B